Skip to main content
Watch Insiders
REGNHealthcare

Regeneron Pharmaceuticals, Inc. (REGN) Insider Trading

In the last 90 days, 4 Regeneron Pharmaceuticals, Inc. (REGN) insiders reported no open-market purchases and 5 sales totaling $6,506,834. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 14, 2026Andrew J MurphyCo-Chief Scientific OfficerSale4,147$772.70$3,204,376
Sep 3, 2026Marion McCourtEVP CommercialSale2,346$853.56$2,002,458
Sep 2, 2026Kathryn GuariniCorporate insiderSale400$850.00$340,000
Aug 10, 2026Kathryn GuariniCorporate insiderSale400$800.00$320,000
Aug 10, 2026Huda Y ZoghbiCorporate insiderSale800$800.00$640,000
Jul 2, 2026Arthur F RyanCorporate insiderSale200$650.15$130,030
May 1, 2026Arthur F RyanCorporate insiderSale100$705.24$70,524

Common questions

REGN insider trading FAQ

Are REGN insiders buying or selling?
Over the last 90 days, REGN insiders were net sellers, reporting $0.00 of open-market purchases and $6,506,834 of sales.
When was the last REGN insider purchase?
No open-market insider purchase of Regeneron Pharmaceuticals, Inc. stock was reported in the last 90 days.
Where does REGN insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Regeneron Pharmaceuticals, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.